Durgical
EN
Open the app

Diagnosing diabetes and telling the types apart

  • Diagnostic approach

Diabetes is diagnosed with simple blood tests, but the type decides the treatment. Getting the type wrong can send a patient into ketoacidosis.

Updated

See it in 3D: Pancreas

What it is

Diabetes mellitus is chronic hyperglycaemia from too little insulin, insulin that works poorly, or both. It is diagnosed by any of: fasting plasma glucose of 126 mg/dL (7.0 mmol/L) or more; plasma glucose of 200 mg/dL (11.1 mmol/L) or more two hours after a standard oral glucose load; HbA1c of 6.5% (48 mmol/mol) or more; or a random glucose of 200 mg/dL or more with classic symptoms. Without symptoms, two abnormal results are needed. The main types are type 1 (autoimmune destruction of beta cells), type 2 (insulin resistance with progressive beta-cell failure), gestational diabetes and specific types: monogenic diabetes (MODY), diseases of the exocrine pancreas, endocrine diseases (Cushing syndrome, acromegaly) and drug-induced diabetes (glucocorticoids, antipsychotics, immune checkpoint inhibitors).

What to know

  • Prediabetes: fasting glucose 100–125 mg/dL, HbA1c 5.7–6.4%, or a two-hour glucose of 140–199 mg/dL; it carries a high risk of type 2 diabetes and of cardiovascular disease.
  • HbA1c misleads when red-cell lifespan or haemoglobin is abnormal: anaemia, haemoglobin variants, recent transfusion or bleeding, pregnancy, advanced kidney disease (iron deficiency raises it, haemolysis lowers it).
  • Islet antibodies: GAD65, IA-2, ZnT8 and insulin autoantibodies.
  • C-peptide shows the patient's own insulin production: low in established type 1, normal or high in type 2 and MODY.
  • Latent autoimmune diabetes of adults (LADA): adult onset, antibody positive, slower progression to insulin dependence; often mislabelled type 2.
  • MODY: autosomal dominant, onset usually before about 25, not obese, antibody negative. GCK-MODY causes mild, stable fasting hyperglycaemia that usually needs no treatment; HNF1A-MODY responds very well to sulfonylureas.
  • Ketosis-prone type 2 diabetes, seen more in Hispanic and African-descent populations, can present with ketoacidosis and later be managed without insulin.
  • Diabetes is a leading cause of kidney failure, blindness, lower-limb amputation, heart attack and stroke worldwide.

Step-by-step approach

  1. Confirm the diagnosis with laboratory plasma glucose or HbA1c, repeated if the patient has no symptoms.
  2. Look at the whole picture: age, weight, speed of onset, weight loss, ketones, family history, other autoimmune disease.
  3. If the type is not clearly type 2 (lean, young, ketosis, rapid course, other autoimmunity): measure islet antibodies.
  4. Measure C-peptide when the type is uncertain, ideally away from severe hyperglycaemia.
  5. Antibody-negative, young, lean, with diabetes in several generations: consider genetic testing for MODY.
  6. Look for secondary causes: pancreatitis or pancreatic surgery, haemochromatosis, cystic fibrosis, glucocorticoids, Cushing syndrome, acromegaly.

The types of diabetes side by side

FeatureType 1Type 2MODYLADA
Typical onsetChildhood or young adulthood, but any ageAdulthood; increasingly in young people with obesityBefore about 25, in every generationAdulthood
Body buildUsually leanUsually overweightUsually leanUsually lean
Islet antibodiesPositiveNegativeNegativePositive
C-peptideLow or absentNormal or highPreservedFalls over years
KetoacidosisCommon at onsetUncommon (with severe stress)RareUncommon early
InsulinNeeded from diagnosisOften only after yearsDepends on the geneNeeded within years

Keys to the differential

  • A capillary meter is fine for monitoring but not for diagnosis: use laboratory plasma glucose or HbA1c.
  • Gestational diabetes is screened for during pregnancy and needs retesting after delivery, because many women later develop type 2 diabetes.
  • In Colombia, diabetes screening and follow-up are part of the cardiovascular risk programmes of the primary-care routes.

Next step / Initial management

  • Fasting plasma glucose, HbA1c or an oral glucose tolerance test; repeat to confirm in people without symptoms.
  • Islet antibodies and C-peptide when the type is uncertain.
  • Type 2: lifestyle change and, unless contraindicated, metformin; add drugs with heart or kidney benefit when indicated. Type 1: insulin from diagnosis.
  • Refer to endocrinology type 1, suspected MODY or LADA, diabetes in children or pregnancy, and any patient whose type is unclear.

Common traps

  • Every adult with diabetes has type 2: antibody-positive LADA gets delayed insulin and can present in ketoacidosis.
  • HbA1c is reliable in every patient: it misleads in anaemia, haemoglobin variants, pregnancy or advanced kidney disease.
  • One abnormal result diagnoses diabetes even without symptoms: in a person without symptoms, do not diagnose from a single abnormal result.
  • A young person with obesity has type 2 diabetes: type 1 occurs at any weight.
  • Every mild stable hyperglycaemia needs treatment: GCK-MODY causes it and needs no treatment.

Test yourself

Think of the answer, then tap the question to see it.

A lean 42-year-old diagnosed with type 2 diabetes fails oral drugs within a year. Which tests do you order and why?

Islet antibodies and C-peptide: positive antibodies with falling C-peptide suggest LADA, which needs insulin.

A 19-year-old with mild fasting hyperglycaemia has a father and grandmother with «mild diabetes» and negative antibodies. What do you suspect?

MODY, probably GCK-MODY: autosomal dominant, antibody negative, with mild stable fasting hyperglycaemia that often needs no treatment.

A woman with sickle cell disease has an HbA1c of 5.4% but fasting glucose of 140 mg/dL twice. Which result do you trust?

The fasting glucose: haemolysis shortens red-cell life and falsely lowers HbA1c. She meets the criteria for diabetes.

Add to my cards (3)

Elsewhere in DurgiPedia

Connections

← All of endocrinology

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: Type 1 Diabetes (StatPearls (NCBI Bookshelf), 2024); Type 2 Diabetes (StatPearls (NCBI Bookshelf), 2023); Hemoglobin A1C (StatPearls (NCBI Bookshelf), 2025); Maturity Onset Diabetes in the Young (StatPearls (NCBI Bookshelf), 2023); Latent Autoimmune Diabetes (StatPearls (NCBI Bookshelf), 2024); Diabetes (fact sheet) (World Health Organization, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.